Solving the mystery of an old diabetes drug that may reduce cancer risk

In 2005, news first broke that researchers in Scotland found unexpectedly low rates of cancer among diabetics taking metformin, a drug commonly prescribed to patients with Type II diabetes. Many follow-up studies reported similar findings, some suggesting as much as a 50-per-cent reduction in risk.

Read the whole article on Physorg

More from Physorg